ESMO Preceptorship on NSCLC Singapore December 2016

Oncology Meeting Resources

13 Dec - 14 Dec, Singapore, Singapore

ESMO Preceptorship

Main learning objectives for the ESMO Preceptorship on NSCLC Singapore 2016 included learning about best clinical practice in the management of Non-Small-Cell Lung Cancer (NSCLC) in the adjuvant, locally advanced and metastatic setting; understanding the importance of pathology and histoprognostic factors in the management of NSCLC and learning about the management of patients after progression, side-effects of treatments, and the use of targeted agents in NSCLC

Presentations from the Preceptorship are now available here. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links

Presenter Presentation title Session title
Y-L. Wu, CN Strategic Approaches: Sequence of Use of Targeted Agents and Chemotherapy and Definition of Progression Under TKI; Intercalating Anti-EGFR with Chemotherapy Session 4 Future Development
J. Bennouna, FR Immunotherapy Session 4 Future Development
E. F.Smit, NL 2nd and Later Lines of Treatment Session 4 Future Development
J-Y. Douillard, CH Welcome from ESMO, Objectives and Scientific Introduction Opening and Welcome